Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension

NCT02999906 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped For business reasons.

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Oral Treprostinil
DRUG: Placebo

Sponsor

United Therapeutics